DIG
TRAW icon

Dauntless Investment Group’s Traws Pharma TRAW Stock Holding History

Dauntless Investment Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.9K Sell
80,574
-336,424
-81% -$464K 0.05% 51
2026
Q1 		$763K Buy
+416,998
New +$784K 0.51% 24

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Dauntless Investment Group's TRAW Position: Q2 2026 in Review

Dauntless Investment Group reduced its Traws Pharma (TRAW) stake by 81% in Q2 2026, selling an estimated $464K and leaving 80,574 shares worth $67.9K. The position accounts for 0.05% of the portfolio, ranked #51.

Dauntless Investment Group first reported a position in TRAW in Q1 2026 and has held it in 2 quarters since. The position peaked at $763K in Q1 2026. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Dauntless Investment Group held 80,574 shares of Traws Pharma worth $67.9K as of Q2 2026.
  • Dauntless Investment Group sold 336,424 Traws Pharma shares in Q2 2026, an estimated $464K.
  • Traws Pharma made up 0.05% of Dauntless Investment Group's portfolio in Q2 2026, its #51 holding.
  • Dauntless Investment Group first reported a position in Traws Pharma in Q1 2026 and has held it in 2 quarters since.
  • Dauntless Investment Group's Traws Pharma position peaked at $763K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.